SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ADVENTRX Pharmaceuticals Inc (Anx)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Keith Feral who wrote (53)5/9/2007 1:13:42 PM
From: Keith Feral of 418
 
ANX is starting to look like the real deal as all of the gnta, dndn, idti, and other biotech stories are coming back to earth.

I keep thinking about all of the anemia warnings the fda is issuing against jnj and amgn for their products. Gives me a lot of hope that Cofactor can be a disruptive technology for chemo by increasing efficacy and eliminating anemia and other side effects.

The conference call from Fortis and the EPS call were amazing. 5 Products in registration trials this year, and the company has not signed any global licensing rights. This leaves tremendous opportunity for shareholders.

Look at ISIS and BMY. BMY paid $15 million as a signing bonus and $9 million for clinical trials. They are paying the big bucks, $168 million for regulatory approval. Hell, ANX is almost halfway through their phase 3 as enrollment is completed by next summer. In the meantime, the company has phase 2 b data from Europe in a few weeks and interim phase 3 data coming out for the 300 patient study in 2008.

They don't need any financial assistance to get through the trials, and the partners will be taking much less risk since they already have a good idea what the data looks like. This will give Adventrx much better negotiating terms with Icahn at the table and a viable first line chemo drug which is being used in 80 of first line treatments today - leucovorin.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News